Risk factors for colon adenomas recurrence after endoscopic mucosal resection

Author:

Vaganov Yu. E.1ORCID,Veselov V. V.1,Likutov A. A.2ORCID,Khomyakov E. A.2ORCID,Chernyshov S. V.1ORCID,Abdulzchalieva E. U.1,Achkasov S. I.2ORCID

Affiliation:

1. Ryzhikh National Medical Research Center of Coloproctology

2. Ryzhikh National Medical Research Center of Coloproctology; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of Russia

Abstract

Aim: to identify risk factors for neoplasms recurrence removed by endoscopic mucosal resection (EMR).Patients and methods: the single-center retrospective observational study included 207 patients with 260 benign colon neoplasms. There were 95 (45.9%) males and 112 (54.1%) females. The median age of the patients was 67 (27-80) years. The results obtained were assessed using following criteria: morbidity rate, complication type, hospital stay, tumor site, number of neoplasms in colon, lateral growth, fragmentation rate, technical difficulties (mucosal fold convergence)during surgery, grade of dysplasia, recurrence rate.Results: intraoperative fragmentation of the neoplasms during mucosectomy occurred in 48/260 (18.5%) cases. Postoperative complications within the period of up to 30 days occurred in 13/207 (6.3%) patients. The most frequent 9 (4.2%) postoperative complication arising after mucosectomy was post-polypectomy syndrome. Another 4 (2.0%) patients produced bleeding after the surgery, which required repeated endoscopic procedure. No mortality occurred. The tumor size exceeding 25 mm (Exp (B) = 0.179; 95% CI = 0.05-0.7; p = 0.014), severe dysplasia (Exp (B) = 0.113; 95% CI = 0.03-0.4; p = 0.001) and fold convergence (Exp (B) = 0.2; 95% CI = 0.07-0.7; p = 0.015) are independent risk factors for disease recurrence.Conclusion: mucosectomy is indicated for colon adenomas if its size does not exceed 25 mm and can be removed en bloc.

Publisher

Russian Association of Coloproctology

Subject

Materials Chemistry

Reference22 articles.

1. Kaprin A. D., Starinsky V.V., Petrova G.V. Malignant neoplasms in Russia in 2018 (morbidity and mortality). Moscow: mnioi. P.A. Herzen (branch FGBU "MICR" of Minzdrav of Russia), 2019. [in Russ.].

2. Kashchenko V.A., Volkova E.S., Lobach S.M., Vanyan V.A. Screening of colorectal cancer. Clinical hospital. 2019; no.1 (27), pp. 18-23. [in Russ.].

3. Buchner A.M., Guamer-Argente C., Ginsberg G.G. Outcomes of EMR of defiant colorectal lesions directed to an endoscopy referral center. Gastrointest Endosc. 2012; 76(2):255-263.

4. Armashov V.P., Armashov O.Yu., Pavlenko V.V., et al. Results of endoscopic treatment of epithelial polypoid neoplasms of the colon and rectum. Evidence-Based gastroenterology. 2019; v.8, no.1, pp.43. [in Russ.].

5. Galimov O.V., Khanov V.O., Karimov M.A. et al. Gastrointestinal benign tumor treatment experience. The Bulletin of Contemporary Clinical Medicine. 2020; no.13(2), pp.36-41. [in Russ.]. DOI: 10.20969/VSKM.2020.13(2).36-41

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3